Encompass Health jumps as Q1 results top expectations and 2026 guidance rises
EHC•Encompass Health shares rose after the company reported Q1 2026 results and raised full-year 2026 guidance. Q1 net operating revenue increased 9.0% to $1.5866 billion, with adjusted EBITDA up 11.2% to $348.8 million.
1. What’s moving the stock
Encompass Health (EHC) is trading higher after releasing first-quarter 2026 earnings and increasing its full-year 2026 outlook. The update showed continued volume growth in inpatient rehabilitation, improving profitability metrics, and management confidence signaled through a guidance lift. (stocktitan.net)
2. The key numbers investors are reacting to
For Q1 2026, Encompass Health reported net operating revenue of $1.5866 billion (up 9.0% year over year), adjusted EBITDA of $348.8 million (up 11.2%), and income from continuing operations per diluted share of $1.77 (up 19.6%). Adjusted EPS was $1.60 versus $1.37 a year ago, while discharges rose to 67,763 (up 4.3%). (stocktitan.net)
3. Guidance lift and growth plan
The company modestly raised its 2026 outlook, with net operating revenue now expected at $6.375 billion to $6.470 billion, up from the prior $6.365 billion to $6.465 billion range. Management also reiterated an expansion pipeline, including plans to open eight hospitals (389 beds) and add roughly 175 beds in 2026, building on Q1 capacity additions and a new hospital opening in South Carolina. (stocktitan.net)
4. The risk check traders will watch next
Despite the upbeat prints and higher guidance, investors will monitor whether cash generation rebounds after adjusted free cash flow fell 12.9% year over year to $193.8 million in Q1. Attention is also likely to stay on reimbursement dynamics, audit activity, and staffing-cost pressure given the sector’s sensitivity to labor trends and payor changes. ()
